Abridge

Abridge is a Pittsburgh-based healthcare AI company that has emerged as the leader in generative AI for clinical documentation. Founded in 2018 by cardiologist Dr. Shiv Rao, the company uses artificial intelligence to automatically convert patient-clinician conversations into structured clinical notes, saving doctors an average of 3 hours per day and addressing the epidemic of physician burnout.

The company has experienced extraordinary funding growth, raising approximately $800 million to date including a $300 million Series E in June 2025 (led by Andreessen Horowitz and Khosla Ventures) that valued the company at $5.3 billion. This followed a $250 million Series D just four months earlier at $2.8 billion valuation, demonstrating unprecedented investor enthusiasm for healthcare AI.

Abridge's technology is now deployed across more than 150 health systems, including UPMC (scaling to 12,000 clinicians enterprise-wide), Mayo Clinic, Johns Hopkins, and Emory Healthcare. The platform leverages a proprietary dataset derived from over 1.5 million medical encounters to power its AI models.

Through deep integration with Epic (the dominant electronic health records system), Abridge has established a defensible market position. The company has also expanded into emergency medicine and nursing documentation, broadening its addressable market while maintaining focus on reducing administrative burden for healthcare providers.